Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.660
+0.110 (7.10%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Humacyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-148.7-110.78-11.97-26.48-66.52
Upgrade
Depreciation & Amortization
7.197.728.218.248.35
Upgrade
Other Amortization
-0.481.550.98-
Upgrade
Loss (Gain) From Sale of Assets
00.020.01-0.18
Upgrade
Stock-Based Compensation
6.146.836.1810.154.69
Upgrade
Other Operating Activities
36.9415.85-76.14-73.520.1
Upgrade
Change in Accounts Receivable
-0.030.15-0.060.49
Upgrade
Change in Accounts Payable
-1.964.81-0.51-0.2-0.89
Upgrade
Change in Other Net Operating Assets
2.271.731.39-0.3-1.97
Upgrade
Operating Cash Flow
-98.12-73.31-71.13-81.19-55.57
Upgrade
Capital Expenditures
-1.57-2.28-1.05-0.22-0.32
Upgrade
Sale of Property, Plant & Equipment
----0.05
Upgrade
Investment in Securities
-2.115.89-8-
Upgrade
Investing Cash Flow
-1.57-0.174.85-8.22-0.27
Upgrade
Long-Term Debt Issued
---29.663.25
Upgrade
Long-Term Debt Repaid
-2.58-34.07-1.98-1.73-1.5
Upgrade
Net Debt Issued (Repaid)
-2.58-34.07-1.9827.931.75
Upgrade
Issuance of Common Stock
94.840.570.542430.3
Upgrade
Other Financing Activities
21.9238.01--3.95-
Upgrade
Financing Cash Flow
114.184.51-1.45266.982.05
Upgrade
Net Cash Flow
14.49-68.97-67.73177.57-53.78
Upgrade
Free Cash Flow
-99.69-75.59-72.18-81.41-55.89
Upgrade
Free Cash Flow Margin
---4611.95%-6445.76%-3748.22%
Upgrade
Free Cash Flow Per Share
-0.84-0.73-0.70-2.04-9.69
Upgrade
Cash Interest Paid
-1.612.671.12-
Upgrade
Levered Free Cash Flow
-65.38-45.28-40.66-34.63-31.56
Upgrade
Unlevered Free Cash Flow
-59.58-41.64-38.33-32.89-30.19
Upgrade
Change in Net Working Capital
-0.16-6.68-1.190.312.54
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q